Skip to main content
Mercator Medical logo

Mercator Medical — Investor Relations & Filings

Ticker · MRC ISIN · PLMRCTR00015 LEI · 259400YONW18M3H4WX66 WAR Manufacturing
Open in API
Filings indexed 1,123 across all filing types
Latest filing 2020-04-14 Earnings Release
Country PL Poland
Listing WAR MRC

About Mercator Medical

https://en.mercatormedical.eu/

Mercator Medical is a manufacturer of medical gloves and a distributor of single-use medical materials. The company's core product portfolio includes a variety of disposable gloves, such as surgical, diagnostic, sterile, and protective types, alongside other disposable medical supplies. It operates on a dual model: as a manufacturer with a global distribution network selling to numerous countries worldwide, and as a distributor primarily focused on European markets. The business centers on providing single-use medical devices and personal protective equipment.

Recent filings

Filing Released Lang Actions
Szacunkowe wyniki pierwszego kwartału 2020 r. - Content (PL)
Earnings Release Classification · 99% confidence The document text is in Polish and presents preliminary, estimated financial results (revenues, EBITDA, net income) for the first quarter (I kwartał) of 2020, comparing them to previous periods (Q4 2019 and Q1 2019). This content—the initial announcement of key financial highlights for a specific period (quarterly)—perfectly matches the definition of an Earnings Release (ER). The text explicitly states these figures are preliminary and the consolidated financial statement is still being prepared, confirming it is the initial release, not the full report. Q1 2020
2020-04-14 Polish
Powiadomienie o transakcjach
Director's Dealing Classification · 99% confidence The document is titled "Powiadomienie o transakcji/transakcjach*, o którym mowa w art. 19 ust. 1 rozporządzenia MAR" (Notification of a transaction(s) referred to in Article 19(1) of the MAR Regulation). It details a transaction (Zbycie/Disposal) involving shares of Mercator Medical S.A. by a member of the Supervisory Board (Piotr Solorz) on a specific date (2020-01-31). This structure and content directly correspond to insider trading reports mandated by market abuse regulations (MAR Article 19), which track personal share transactions by directors and executives. This matches the definition for Director's Dealing (DIRS).
2020-04-08 Polish
Transakcje osoby pełniącej obowiązki zarządcze - Content (PL)
Director's Dealing Classification · 98% confidence The document text is very short (249 characters) and originates from a Polish entity ("Zarząd spółki Mercator Medical S.A."). The core content states that the Management Board received a notification on April 7, 2020, from a Supervisory Board member regarding transactions in the Issuer's shares ("powiadomienie o transakcjach na akcjach Emitenta"). This directly describes an insider transaction report being received. This aligns perfectly with the definition of Director's Dealing (DIRS), which covers reports of personal share transactions by company directors and executives.
2020-04-08 Polish
Zawarcie znaczącej umowy - Content (PL)
Regulatory Filings Classification · 95% confidence The document is a short announcement (670 characters) from the Management Board ('Zarząd spółki') of Mercator Medical S.A. It details the cumulative value of supply agreements entered into by a subsidiary (MMT) with a US entity (Ammex) between February 28, 2020, and April 3, 2020. Crucially, it states that this value (56,598 thousand PLN) exceeded 10% of the consolidated sales revenue for the last four reporting quarters. This type of disclosure, concerning significant transactions with related parties or major contracts that cross a materiality threshold (often 10% of revenue/assets), is typically classified as a general regulatory disclosure or a significant transaction notice. Since there is no specific category for 'Significant Contract Disclosure' or 'Related Party Transaction Disclosure' that fits this context perfectly, and given the short nature suggesting an announcement rather than a full report, the most appropriate fallback category is 'Regulatory Filings' (RNS), as it is a mandatory disclosure of a material event.
2020-04-03 Polish
Oświadczenie Rady Nadzorczej dotyczące Komitetu Audytu
Audit Report / Information Classification · 95% confidence The document is titled 'OŚWIADCZENIE RADY NADZORCZEJ' (Statement of the Supervisory Board) of Mercator Medical S.A. It explicitly references Polish Ministry of Finance regulations concerning the functioning of the Audit Committee ('Komitetu Audytu'). The content confirms compliance with rules regarding the composition, functioning, and independence criteria of the Audit Committee. This type of formal declaration regarding internal governance structures, compliance, and board oversight mechanisms aligns best with Governance Information (CGR), which covers internal rules and board structure, rather than a general Audit Report (AR) or a Director's Dealing report. FY 2019
2020-03-30 Polish
Ocena sprawozdań dokonana przez Radę Nadzorczą
Report Publication Announcement Classification · 99% confidence The document is titled 'OCENA RADY NADZORCZEJ MERCATOR MEDICAL S.A. DOTYCZĄCA SPRAWOZDANIA Z DZIAŁALNOŚCI... ORAZ SPRAWOZDANIA FINANSOWEGO... ZA ROK 2019' (Assessment by the Supervisory Board regarding the Management Board's Report on Activities... and the Financial Report... for the year 2019). It explicitly details the Supervisory Board's positive assessment of the Financial Statements (prepared under IFRS) and the Management Board's Report on Activities for the full year 2019, referencing the auditor's report. This document is the formal opinion/assessment provided by the Supervisory Board concerning the annual reports, which is a key component of corporate governance reporting, often preceding the Annual General Meeting (AGM) or being filed alongside the annual reports. Since it is the Supervisory Board's formal opinion on the annual reports, it aligns best with Governance Information (CGR) or potentially an Audit Report/Information (AR) context, but given the focus on the board's assessment and recommendation to the General Meeting, CGR is a strong fit for governance documentation. However, since the core content revolves around the approval of the *Annual Report* and *Financial Statements* for the full year 2019, and it is a formal opinion required by Polish commercial code, it is closely related to the comprehensive annual reporting cycle. Given the options, 'Governance Information' (CGR) captures the nature of the Supervisory Board's assessment best, as it details internal oversight and approval processes related to statutory reports. It is not the 10-K itself, nor is it a general Audit Report (AR) which usually focuses only on the auditor's findings. It is the board's formal governance action on those reports.
2020-03-30 Polish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.